Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. NVDA
4. MSTR
5. MU
6. DFTX
7. BAUFF
8. ICE
9. KR
10. RGA

Go back to Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 22.61 +0.28 (1.25%)
Previous Close $22.33    52 Week High $80.25 
Open $22.21    52 Week Low $30.25 
Day High $22.61    P/E N/A 
Day Low $22.00    EPS $-2.08 
Volume 260,119       

PACIRA (NASDAQ: PCRX) Delayed: 22.61 +0.28 (1.25%)
Previous Close $22.33    52 Week High $80.25 
Open $22.21    52 Week Low $30.25 
Day High $22.61    P/E N/A 
Day Low $22.00    EPS $-2.08 
Volume 260,119